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1. Introduction  
Preterm parturition is a syndrome (Romero, Gomez et al., 1997; Romero R, Espinoza J et al., 
2004) that is one of the leading causes for perinatal morbidity and mortality. Moreover, 
prematurity is a leading cause for neonatal mortality, as well as short and long term 
morbidity. The incidence of preterm delivery is constantly increasing, crossing the 12% in 
the USA, and it's annual cost reached 26.2 billion US dollars in 2005, posing a huge burden 
on public health (Institute of Medicine (US) Committee on Understanding Premature Birth 
and Assuring Healthy Outcomes, 2007). 
Prematurity can be either spontaneous due to preterm labor with intact membranes (PTL) or 
preterm prelabor rupture of the chorioamniotic membranes (preterm PROM); or indicated, 
meaning induced preterm delivery by the medical team due to maternal (i.e. preeclampsia) 
or fetal (growth restriction, non-reassuring fetal heart rate tracing) indication (Goldenberg, 
Culhane et al., 2008). The incidence of the latter group, especially after 34 weeks of gestation, 
is constantly rising (Ananth, Joseph et al., 2005; Ananth and Vintzileos, 2006a; Ananth, 
Getahun et al., 2006).  
Emerging contributors for the increasing rate of preterm birth are assisted reproduction 
technologies (Institute of Medicine (US) Committee on Understanding Premature Birth and 
Assuring Healthy Outcomes, 2007). The use of infertility treatments has risen dramatically 
in the past 20 years; between 1996 and 2003, the number of cycles of Assisted reproductive 
technologies (ART) nearly doubled from 64,681 to 122,872. The number of live births 
resulting from conceptions achieved by the use of ARTs more than doubled from 14,507 to 
35,785 (Institute of Medicine (US) Committee on Understanding Premature Birth and 
Assuring Healthy Outcomes, 1980). This has been associated with the trend to delay 
childbearing, indeed, more than 50 percent of these women were 35 years of age or older. In 
recent years, an unintended consequence of the use of these technologies, multiple 
gestations and the increased risk for preterm delivery, has become a focus of attention, and 
the institute of Medicine in the USA has concluded that "Fertility treatments are a significant 
contributor to preterm birth among both multiple and singleton pregnancies." (Institute of 
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Medicine (US) Committee on Understanding Premature Birth and Assuring Healthy 
Outcomes, 2007). 
The mechanisms in which assisted reproduction technologies increases the risk for preterm 
birth are still under investigation. Aside the contribution of ART to the increase number of 
multiple gestations (especially twins) that increases the risk for preterm delivery; The 
mechanisms leading to preterm delivery in singleton gestations conceived through ART 
have not been thoroughly investigated. Preliminary evidence suggests that some of the 
underlying maternal conditions that lead to infertility (i.e. inflammation and insulin 
resistance) may contribute to this observation.  
The current chapter will explore the epidemiology, underlying mechanisms, and possible 
tools for the prevention of preterm delivery in pregnancies conceived by assisted 
reproduction.  
2. Infertility: Treatments, epidemiology and trends 
2.1 Definitions 
The most commonly used definition of infertility is a failure to conceive after 12 months of 
regular, unprotected intercourse. However, existing definitions of infertility lack uniformity, 
rendering comparisons of prevalence between countries or over time problematic. The 
absence of an agreed definition also compromises clinical management and undermines the 
impact of research findings. Gurunath at al suggested that the definition will be based on 
the duration of trying for pregnancy coupled with female age. (Gurunath, Pandian et al., 
2011) According to the report of The Centers for Disease Control and Prevention (CDC), in 
2002, 7% of married couples in which the woman was of reproductive age (2.1 million 
couples) reported that they had not used contraception for 12 months and the woman had 
not become pregnant. Many of these patients are treated by ARTs. These technologies are 
defined by the CDC as procedures in which the ovum and the sperm are handled in the 
laboratory. During the past few decades several options of ART have developed including: 
1) in vitro fertilization (IVF); 2) intra-cytoplasmic sperm injection (ICSI); 3) gamete intra-
fallopian transfer (GIFT) and 4) zygote intra-fallopian transfer (ZIFT) (Centers for Disease 
Control and Prevention 2008). 
2.2 What is the magnitude of ART utilization in developed countries? 
The use of infertility treatments has risen dramatically in the past 10 years and has been 
associated with the trend to delay childbearing. Today, over 1% of all infants born in the 
United States every year are conceived using ART; and the number of ART cycles 
performed has nearly doubled, from 87,636 cycles in 1999 to 148,055 in 2008. Similarly, the 
number of live-birth in 2008 (46,326) was more than twice the number recorded 1999 
(21,746). Because in many of the ART pregnancies more than one infant is born alive (e.g., 
twins, triplets), the total number of infants born is greater than the number of live-birth. The 
trend in the number of infants delivered after ART cycles was in accord to the trends 
observed in the number of pregnancies and live-births. Thus, the number of infants born in 
2008, (61,426) was more than twice than the 30,629 that were delivered in 1999 (Figure 1).  
Outside the USA, The Canadian Assisted Reproductive Technologies Register (CARTR), in 
its 2007 annual publication, reported a 12% increase in the total number of ART cycles, and 
an increase in the rate of clinical pregnancies and live-birth, along with a decrease in high-
order multiple births in comparison to these parameters in 2006 (Gunby, Bissonnette et al., 
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2011). While in Europe, according to the 10th annual European Society of Human 
Reproduction and Embryology (ESHRE) publication the reported number of ART cycles has 
increased, with a marginal increase in pregnancy rates, even though fewer embryos were 
transferred and the multiple delivery rates have declined (1994). This report includes 20 
countries, where all clinics report their activity to the IVF register. Altogether, a total of 
359,110 cycles were performed in a population of 422.5 million, corresponding to 850 cycles 
per million inhabitants. The IVF cycles rates of clinical pregnancy per ovum aspiration and 
per embryo transfer were 29.0 and 32.4%, respectively; while the corresponding ICSI cycles 
rates were 29.9 and 33.0%, respectively (1994). In spite of the new guidelines, transferring of 
2 embryos is still the most prevalent choice in the European Union.  
 
 
Fig. 1. Number of ART cycles performed, live-birth delivery, and infants born used ART, 
1999-2008 From Centers for Disease Control and Prevention, American Society for 
Reproductive Medicine, Society for Assisted Reproductive Technology. 2006 Assisted 
Reproductive Technology Success Rates: National summary and fertilityNclinic reports. 
Atlanta: Centers for Disease Control and Prevention,2008.  
ART often is categorized according to whether the procedure used a woman’s own eggs 
(self) or eggs from another woman (donor) and according to whether the embryos used 
were newly fertilized (fresh) or previously fertilized, frozen, and then thawed (frozen). For 
approximately 71% of ART cycles performed in USA in 2008, self-fresh eggs or embryos 
were used. ART cycles that used self-frozen embryos were the next most common type, 
accounting for approximately 17% of the total. In about 12% of cycles, eggs or embryos were 
donated by another woman (Figure 2). 
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Fig. 2. Distribution of ART cycles according to the source of the ovum and whether the cycle 
was fresh or frozen. (CDC 2008, USA).  
The average age of women using ART services in the USA in 2008 was 36. However, the 
largest group of women using ART services were women younger than 35, representing 
approximately 39% of all ART cycles performed in 2008. Approximately 21% of ART 
cycles were performed in women aged 35–37, 20% in women aged 38–40, 10% in women 
aged 41–42, 6% in women aged 43–44, and 5% among women older than 44 ( Figure 4). In 
Europe, the age distribution of women treated with IVF varied across the continent. In 
some countries, more than 20% of women were aged 40 years or older (Greece, Ireland, 
Italy, Macedonia, Montenegro, Serbia and Switzerland), whereas in Bulgaria, Czech 
Republic, Lithuania, Norway, Poland, Portugal, and Ukraine <10% were 40 years or older. 
(ESHRE,2006) 
The success rate of ART decreases with age, indeed, pregnancy rates decreased from 28.2% 
in women aged ≤34, to 9.6% at the age ≥40 years. A similar trend was seen for the delivery 
rates (26.6%, and 8.6%). In egg donation cycles, the recipients were aged 40 years or more in 
50.0% of cases, in almost all countries. Pregnancy and delivery rates in oocyte recipients 
were comparable across different age groups. (ESHRE,2006) 
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Fig. 3. Maternal age distribution among patients undergoing ART cycles. CDC 2008 USA.  
3. The effect of maternal age on reproduction and pregnancy outcome 
The average fertility rate (live births per 1,000 women of childbearing age 15–44 years) in 
USA from 1991-2008 is about 66.5, with mild fluctuations over the years. When it is divided 
in subgroups by maternal age, the birth rate has declined for women under 30-s on the other 
hand among women in their 30's- 40's the fertility rate had steadily increased from 1978 
onward. In the last three decades a new group of women aged 50 and over has increased 
more than 10 percent annually since 1997 (Martin, Hamilton et al., 2010). The trend in the 
fertility rate among European women is somewhat different. From the 1960s up to the 
beginning of the 21st century, the number of live births in the Europe declined sharply. 
However, from 2002 onward there has been a modest rebound in the number of live births 
born in this continent. As with the American women, the late increase during the last years 
may be, in part, attributed to a catching-up process following a general pattern of 
postponing the child bearing age. When women give birth later in life, the total fertility rate 
first indicates a decrease in fertility, followed later by a recovery (Atkinson and Marlier, 
2010). For example, in Finland the rate of women giving birth after the age of 35 increased 
from 16.7%in 1997 to 19.2% in 2007 (Lampinen, Vehvilainen-Julkunen et al., 2009). The 
corresponding mean maternal age in Japan between 1970 and 2000 increased from 25.6 to 
28.0 years (Mathews and Hamilton, 2002). 
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Delaying childbearing may be attributed to several reasons, beginning with the longer life 
span, greater accessibility to education and career opportunities for women, and the 
existence of effective means of birth control (Stein, 1985; Berkowitz, Skovron et al., 1990). 
Men and women recognized the direct relationship between older maternal age and the 
declined in fertility (Tough, Benzies et al., 2006; Tough, Benzies et al., 2007), however, there is 
a popular concept that IVF treatment can reverse the effects of age (Maheshwari, Porter et 
al., 2008). Interestingly, along with acknowledgment in the success of ART there is a lack of 
awareness regarding the effect of maternal age over perinatal complications during 
pregnancy. Women are not aware of the increased risk of preeclampsia, stillbirth, caesarean 
delivery, multiple births and preterm delivery associated with delayed childbirth to elderly 
stages of life (Tough, Benzies et al., 2006; Tough, Benzies et al., 2007). 
Postponement of motherhood beyond 35 years of age influences many aspects of 
reproduction from conceiving through embryonic implantation all the way until delivery. 
The effect of maternal age on her ability to conceive is well documented. Populations that do 
not use contraceptives and practice unprotected intercourse give the best estimation of the 
ability of normal women to conceive. Based on 10 different populations living between the 
17th and the 20th Centuries that did not use contraceptives, Menken et al (Menken, Trussell 
et al., 1986) reported that the fertility rate remains relatively stable until a woman is in her 
late 30s and then decreases substantially from more than 400 pregnancies per 1000 women 
per year at the age of 30, to only 100 pregnancies per 1000 women per year by the age of 45. 
The decline in fertility as a function of women's age was also demonstrated in a donor 
insemination programmed in which the cause of infertility was related to male factors alone 
and the women were assumed to be normal. Pregnancy rates at 1 year declined from 74% 
among women below the age of 30 years to 61.5% among women aged 31–35 years and 
55.8% among women aged 36–41 years (Schwartz and Mayaux, 1982).  
After conceiving, the risk of spontaneous miscarriage increases as a function of maternal 
age. In a prospective population-based register linkage study, involving 12,221,546 
pregnancies of 634,272 Danish women from 1978 to 1992, older maternal age was a 
significant risk factor for spontaneous pregnancy loss irrespective of the number of previous 
miscarriages and parity. The risk of a spontaneous abortion in women aged 20–24 years was 
8.9% and it climbed up to 74.7% in those aged 45 years or older (Nybo Andersen, Wohlfahrt 
et al., 2000). Ben Kroon et all performed a cytogenetic evaluation for the products of 
conception obtained from patients with first trimester abortion who had a dilatation and 
curettage (D&C). The rate of embryos with aneuploidy in women aged ≥35 years was 
significantly higher than that of those younger than 35 years (45.7%, vs. 34.8%, respectively; 
P=.018) (Kroon, Harrison et al., 2011). The derived rates apply to women whose only risk 
factor is advanced maternal age. The categories analyzed were trisomy 21 (Down's 
syndrome), Trisomy 18 (Edwards' syndrome), trisomy 13 (Patau's syndrome), 47XXY 
(Klinefelter's syndrome), 47,XXX, and a group of other clinically significant abnormalities 
that were considered collectively. The rate of all these chromosomal abnormalities in this 
study was about five per 1,000 at age 35 years, 15 per 1,000 at age 40 years, and 50 per 1,000 
at age 45 years (Hook, Cross et al., 1983). Savva et al (Savva, Walker et al., 2010) reviewed the 
records of prenatal and postnatal diagnoses from seven UK regional congenital anomaly 
registers and two Australian registers from 1997 to 2004. These dataset included 4.5 million 
deliveries, of which 975 diagnosed as having trisomy 13 and 2254 had trisomy 18. In 
addition, the authors reported that since 1989 until 1996 there was an increase, by 13% in the 
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rate of trisomy 13 and by 25% in the rate of trisomy 18. These findings are consistent with 
those predicted to be associated with the increases in maternal age (Savva, Walker et al., 
2010).  
The link between Down syndrome and advanced maternal age deserves special attention. 
This association was already reported by Penrose in the mid 1930's (Penrose, 1933; Penrose, 
1934). Lately, Graves Allen et al (Allen, Freeman et al., 2009) examined the origin of the 
meiotic error leading to the association between maternal age and chromosome 21 non-
disjunction. They emphasis that the a significant association between advanced maternal 
age and chromosome 21 non-disjunction was restricted to meiotic errors in the egg and was 
not observed in sperm or in post-zygotic mitotic errors. The authors reported that the 
advanced maternal age was significantly associated with a higher rate of non-disjunction in 
both meiosis I (MI) and meiosis II (MII). Indeed, compared to mothers of euploid neonates, 
mothers of infants with trisomy 21 due to MI non-disjunction were 8.5 times more likely to 
be ≥40 years old than 20–24 years old at the birth of the index case (95% CI = 5.6–12.9). 
Where non-disjunction occurred in MII, mothers were 15.1 times more likely to be ≥40 years 
(95% CI = 8.4–27.3) (Allen, Freeman et al., 2009). 
Women's age has a major impact on the rate of chronic maternal diseases and pregnancy 
outcome. Indeed, the rate of diabetes increases with maternal age. The 2010 National Vital 
Statistics Reports reported that in 2007 the rate of diabetes among USA mothers under the 
age of 20 was 14.0 per 1,000, and it increases almost 7 times higher to 100.5 per 1,000 in 
women over the age of 40 (Table 1). Similar trends were reported regarding the rate of 
chronic hypertension. The prevalence of this disease increases from 3.9 per 1000 in women 
younger than 20 years old to 32.2 per 1000 in women older than 40. In contrast to the linear 
association between diabetes, as well as chronic hypertension and maternal age, the 
incidence of gestational hypertension as a function of maternal age has a U shape curve with 
a prevalence of 41.8 per 1000 among patients under 20 years and 50.1 per 1000 for women 
over 40, and the lowest incidence is between 20-35 years old. Similarly to the National Vital 
Statistics Reports, a different population based cohort involving 1,160,000 women delivered 
during a 2-year period found increased rate of preeclampsia and gestational diabetes among 
women aged 40 years or older in comparison to those aged 20-29 (Gilbert, Nesbitt et al., 
1999). Yogev et al (Yogev, Melamed et al., 2010) stratified the rate of pregnancy complication 
according to maternal age with a special attention to women aged ≥45 years (n = 177) with 
an additional subgroup analysis of women aged 45-49 years with those women aged ≥50 
years. Similar to previous studies the authors reported that the rates of gestational diabetes 
mellitus and hypertensive complications of pregnancy were increased among women aged 
45 years and older. 
Maternal age also influences perinatal outcome, small-for-gestational age births (SGA) are 
common and can have serious immediate consequences for the infant (Das and Sysyn, 2004; 
Salem, Levy et al., 2011). They have also been associated with the development of a range of 
chronic diseases in subsequent adult life (Nepomnyaschy and Reichman, 2006; Barker, 
2004). There is an association between maternal age and the delivery of an SGA neonate. In 
the FASTER trial, patients aged 35-39 years were at increased risk to a deliver low 
birthweight neonate (adjusted OR 1.6) (Cleary-Goldman, Malone et al., 2005). In addition, 
Salem- Yaniv et al, in a retrospective population based study found a significant increase in 
low birth weight among older women (35–40 and above 40 years of age) in comparison to 
women younger than 35 years old (Salem, Levy et al., 2011). 
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Maternal age Diabetes per 1,000 
live births in 
specified group 
Chronic Hypertension per 1,000 
live births in specified group 
All ages 44.8 11.0 
Under 20 years 14.0 3.9 
20–24 years 25.9 6.4 
25–29 years 42.4 9.9 
30–34 years 59.5 13.6 
35–39 years 78.6 20.4 
40–54 years 100.5 32.2 
Table 1. Number and rate of live births to mothers with selected risk factors during 
pregnancy, obstetric procedures, characteristics of labor and delivery, and congenital 
anomalies, by age and race and Hispanic origin of mother: United States, 2007. (National 
Vital Statistics Reports, Volume 58, Number 24, August 9, 2010) 
The Human Fertilization and Embryology Authority database was examined in order to 
ascertain the predictors of live birth in all IVF cycles undertaken in the UK between 2003 
and 2007 (n = 144,018). This study has found that the odds of low birth weight were reduced 
with increasing maternal age and with a history of a previous pregnancy (either 
spontaneous or following IVF) (Nelson and Lawlor, 2011). Similarly to these findings, Erez 
et al reported that among patients with twin gestation who conceived through ART the rate 
of preeclampsia was higher in women younger than 35 years old than in older parturient 
(Erez, Vardi et al., 2006). These reports suggest that among patients who suffers from 
infertility the background maternal illness may be more severe and with clinical implication 
that is additive to the effect of maternal age.  
Advanced maternal age also influences the rate of preterm delivery. Jacobsson et al 
examined the Swedish Medical Birth Register, managed by the National Board of Health 
and Welfare, contains data on 1,566,313 deliveries that are more than 99% of all births in 
Sweden during the last 15-years. The rate of preterm delivery before 37 and 34 weeks 
among women 20-29 were compared to those of women age 40-44 years and above 45 
years (Jacobsson, Ladfors et al., 2004). The authors reported that the rate of preterm birth 
increases with maternal age. Indeed, after adjustment to confounding factors women aged 
40-44 years old had an odds ratio of 1.54 (95% CI 1.47-1.60), while those who were ≥ 45 
years had an odds of 1.63 (95% CI 1.32-2.00) to deliver before 37 weeks of gestation 
(Jacobsson, Ladfors et al., 2004). Similar data where published also by others (Cleary-
Goldman, Malone et al., 2005; Salem, Levy et al., 2011). 
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Women ≥ 35 years have a significantly higher rate of fetal death than their younger 
counterparts. Fretts and colleagues documented that the fetal death rate decreased by more 
than 70 percent over the past 30 years among white Canadian women. Although the 
absolute stillbirth rate declined significantly for women of all ages and parity groups, older 
women remained at higher risk for fetal death, even after controlling for diabetes, 
hypertension, and placental abruption (Fretts, Schmittdiel et al., 1995). This report was in 
accord with other publications regarding the increased rate of fetal demise among older 
women (Jacobsson, Ladfors et al., 2004; Cleary-Goldman, Malone et al., 2005). In contrast, 
among nulliparous patients advanced maternal age was not an independent risk factor for 
perinatal mortality (Salem, Levy et al., 2011).  
The increasing numbers of pregnancies at advanced maternal age influences the rising rate 
of cesarean birth. Among 57,426 primiparous women who gave birth in Victoria, Australia, 
in 2005 and 2006, older patients were more likely to give birth by cesarean section in 
comparison to younger primiparous women (Carolan, Davey et al., 2011). Salem-Yaniv at al 
reported that in comparison to women younger than 35 years old, those aged 35–40 have an 
almost a threefold increase in the rate of cesarean deliveries among nulliparous patients 
(38.2%) and close to a fivefold increase among women over 40 years (63.3%) (Salem, Levy et 
al., 2011). Similar results were published by the National Vital Statistics Reports UA. Among 
4,316,233 women that delivered during the year 2007, older maternal age was associated to 
delivery through cesarean section (under 20 22.7% 35-39 41.8%: 40-54 47.7%) (Martin, 
Hamilton et al., 2010). This increasing risk of cesarean birth associated with advancing 
maternal age is of importance, because the proportion of women who are delaying 
childbearing is growing, and in addition, the cesarean delivery rate is increasing (Martin, 
Hamilton et al., 2010). 
4. Pregnancy outcome in patients conceived through assisted reproduction 
IVF pregnancies are associated with an increased risk for obstetrics complication including 
gestational diabetes, preeclampsia, placenta previa and neonatal intensive care admission 
(Shevell, Malone et al., 2005; Chen, Wen et al., 2009; Nelson and Lawlor, 2011). A prospective 
database from a large multicenter investigation of singleton pregnancies demonstrated that 
the use of IVF was associated with a significant increase in the risk to develop preeclampsia 
(OR 2.7; 95% CI 1.7–4.4), placental abruption (OR 2.4; 95% CI 1.1–5.2), placenta previa (OR 
6.0; 95% CI 3.4–10.7), and risk of cesarean delivery (OR 2.3; 95% CI 1.8–2.9) (Shevell, Malone 
et al., 2005). A different prospective cohort study that included singleton IVF/ICSI 
pregnancies had more than 4-fold increased risk of stillbirth compared with spontaneously 
conceived singleton pregnancies (Wisborg, Ingerslev et al., 2010a). There is a strong evidence 
to support the association between IVF treatments and preterm birth. Indeed, ART are 
independently associated with preterm birth in singleton as well as in twin gestation.  
5. The association between preterm birth and assisted reproduction 
Preterm delivery is the leading cause for perinatal morbidity and mortality worldwide 
(Goldenberg, Culhane et al., 2008). The annual societal economic burden associated with 
preterm birth in the United States exceeded $26.2 billion in 2005 (Institute of Medicine 
(US) Committee on Understanding Premature Birth and Assuring Healthy Outcomes, 
2007). Preterm birth is associated with short and long term maternal and fetal sequel. The 
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mothers are at risk of recurrent preterm birth and cardiovascular disease later in life. 
(Nardi, Zureik et al., 2006; Smith, Pell et al., 2001) The premature newborn is at risk for 
acute (i.e. respiratory distress syndrome, necrotizing enterocolitis, and intraventricular 
hemorrhage) and chronic (i.e. retinopathy of prematurity, cerebral palsy, broncho 
pulmonary dysplasia) illness, as well as social and behavioral maladjustment later in life. 
(Moster, Lie et al., 2008) The prevalence of preterm birth varies from 6% to 15% of all 
deliveries depending on the geographical and demographical characteristics of the 
population tested. (Romero, Mazor et al., 1994; Martin, Hamilton et al., 2009; Slattery and 
Morrison, 2002).  
In Europe the rate of preterm deliveries varies from 5% to 9% (Slattery and Morrison, 2002), 
while the rate of preterm birth in the United States reached 12.8% by 2006 (Martin, Hamilton 
et al., 2009), 20% higher than in 1990. Of interest, while the rate of early (<34 weeks) preterm 
birth remained relatively constant (2.9% among singleton and 3.3% to 3.6% among multiple 
gestations) the rate of late preterm birth (34-37 weeks) increased among singleton by 19.1% 
(from 6.1% to 8.1%) and by 24.7% among all pluralities from 1990 to 2005 (Martin, Hamilton 
et al., 2007) (Figure 4). 
Preterm delivery can be either spontaneous or medically induced (indicated) regardless of 
the gestational age at delivery. Spontaneous preterm birth account for 75% of all preterm 
deliveries (Meis, Ernest et al., 1987; Meis, Goldenberg et al., 1998; Meis, Michielutte et al., 
1995) and can be the end result of three main clinical presentations: 1) preterm labor with 
intact membranes; 2) preterm prelabor rupture of membranes (preterm PROM); and 3) 
cervical insufficiency. (McElrath, Hecht et al., 2008) Indicated preterm birth results from 
medical intervention due to maternal or fetal complications that necessitate medical 
intervention. (Ananth and Vintzileos, 2006b; Mazaki-Tovi, Romero et al., 2007; Meis, 
Michielutte et al., 1995; Ananth and Vintzileos, 2006a; Ananth, Getahun et al., 2006) 
Although many studies have focused on the rate of preterm birth, (1999; Joseph, Kramer et 
al., 1998; Vintzileos, Ananth et al., 2002) an important consideration is whether these 
deliveries are the result of spontaneous labor or “indicated” preterm deliveries. The need 
for this distinction is based on the premise that the risk factors for recurrent preterm 
PROM, preterm labor with intact membranes, preeclampsia, and/or SGA are different. 
However, recent observations suggest that there may be overlap among these conditions, 
(Ananth and Vintzileos, 2006a; Ananth, Getahun et al., 2006) so that a patient with an 
“indicated” preterm birth may also be at risk for spontaneous preterm birth (Ananth and 
Vintzileos, 2006a; Ananth, Getahun et al., 2006). The converse may also be true (i.e. that a 
patient with a spontaneous preterm birth is at risk for an “indicated” preterm birth in a 
subsequent pregnancy).  
Assisted reproduction technologies are emerging contributors for the increasing rate of 
preterm birth. The use of infertility treatments has risen dramatically in the past 20 years; 
between 1996 and 2003, the number of cycles of ART nearly doubled from 64,681 to 122,872 
(Institute of Medicine (US) Committee on Understanding Premature Birth and Assuring 
Healthy Outcomes, 2007). The number of live births resulting from conceptions achieved by 
the use of ARTs more than doubled from 14,507 to 35,785. This has been associated with the 
trend to delay childbearing, indeed, more than 50 percent of these women were 35 years of 
age or older. In recent years, an unintended consequence of the use of these technologies, 
multiple gestations and the increased risk for preterm delivery, has become a focus of 
attention. Indeed, the institute of Medicine in the USA has concluded that "Fertility 
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treatments are a significant contributor to preterm birth among both multiple and singleton 
pregnancies." (Institute of Medicine (US) Committee on Understanding Premature Birth and 
Assuring Healthy Outcomes, 2007). 
 
 
Fig. 4. Chances over time in the rate of preterm birth according to gestational age at delivery 
and the number of fetuses.  
ART are associated with increased rate of pregnancy complication. Several questions are 
being raised in regard with this topic:1) what are the causes or mechanisms leading for such 
complications? Is it the treatment or the underlying maternal condition that leads to 
infertility? 2) Are these complications due to multiple gestation or they affect also singleton 
gestations? 3) Is there an association with between the ART protocol and adverse pregnancy 
outcome? 
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5.1 The association between ART and multiple gestations 
There is a direct relationship between the rise in the use of assisted reproduction and the 
increasing rate of multiple gestations. This trend is mostly due to the transfer of multiple 
embryos. In spite of the new regulation regarding the maximal embryos transferred during 
IVF cycle. In 2008, among the ART cycles that used fresh non-donor eggs or frozen-thawed 
embryos and progressed to the embryo transfer stage, approximately 38% involved the 
transfer of three or more embryos, about 13% of cycles involved the transfer of four or more 
embryos, and approximately 4% of cycles involved the transfer of five or more embryos. In 
addition, ART conceived pregnancies have a higher rate of zygotic splitting in cycles were a 
single embryo was transferred resulting in increased rate of monochorionic twins than 
spontaneously conceived pregnancies (Blickstein, Jones et al., 2003; Blickstein, Verhoeven et 
al., 1999). Among the 38,631 pregnancies that resulted from ART cycles using fresh non-
donor eggs or embryos, approximately 61% were singleton, 29% were twins, and about 4% 
were triplets or more. Approximately 32% of the pregnancies ending in live births produced 
more than one infant (30% twins and approximately 2% triplets or more). This compares 
with a multiple-infant birth rate of slightly more than 3% in the general U.S. population 
Figure 5. 
 
 
Fig. 5. Risk of having multi-frtus pregnancies and multiple infant live birth from ART cycles 
using fresh non-donor eggs or embryos-US CDC 2008. 
The proportions of multiple birth in Europe is lower than in the USA, and is declining in 
the recent years. Indeed, the proportion of singleton, twin and triplet deliveries after IVF 
and ICSI combined was 79.2, 19.9 and 0.9%, respectively. This gives a total multiple 
delivery rates of 20.8% compared with 21.8% in 2005 and 22.7% in 2004 (ESHRE, 2006). In 
www.intechopen.com
 
Assisted Reproduction and Preterm Birth 
 
13 
an effort to reduce the number of higher-order multiple pregnancies, the American society 
for reproductive medicine (ASRM) and the Society for Assisted Reproductive Technology 
Data (SART) have developed guidelines for the number of embryos to be transferred in 
IVF cycle. 
5.1.1 What is the effect of the mode of conception on the risk for preterm birth in twin 
gestations?  
Twin and higher order of multiple gestation are at increased risk to deliver preterm. 
Nevertheless, the effect of mode of conception on the prematurity rate in twin pregnancies is 
under continues debate. Several studies have stated that twin pregnancies conceived 
through ART have similar perinatal complication rate (Zaib-un-Nisa, Ghazal-Aswad et al., 
2003; Boulet, Schieve et al., 2008). In contrast, other studies and number of meta-analysis 
demonstrated no difference between spontaneously and ART conceived twin (Daniel, 
Ochshorn et al., 2000; Wright, Schieve et al., 2003; Wright, Schieve et al., 2004; Wang, Sullivan 
et al., 2005; Pinborg, 2005; Allen, Wilson et al., 2006; Reddy, Wapner et al., 2007; Chan, 
Mannino et al., 2007; A B and M K, 2008; Shebl, Ebner et al., 2009; Hansen, Colvin et al., 2009; 
Weghofer, Klein et al., 2009; Rossi and D'Addario, 2011; Morcel, Lavoue et al., 2010). 
Verstraelen et al reported in a population based cohort study, that pregnancies conceived by 
ART have a persistent increased risk for preterm delivery (Figure 6), even after correction 
for birth year, maternal age, parity, and for infant sex, caesarean delivery, zygosity, and 
chorionicity (Verstraelen, Goetgeluk et al., 2005).  
 
 
Fig. 6. Kaplan-Meier plot of gestational length in naturally conceived (n=2915) and 
medically conceived (n=1453) twins. Adopted from Verstraelen H et al. BMJ, 2005; 331: 
1173.with permeation. 
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In addition, Erez et al in a population based cohort study reported that ARTs are an 
independent risk factor for preterm birth after adjustment to parity, rupture of membranes, 
severe preeclampsia (Erez, Mayer et al., 2008). In a systematic review and meta-analysis 
including eleven case-control studies that involved 2303 IVF twins and 2326 spontaneously 
conceived twins, as well as, three cohort studies that involved at least 1509 IVF twins IVF 
twins have an increase risk for PTB from 32 to 36 weeks of gestation compared with 
spontaneously conceived twins who were matched for maternal age (OR, 1.48; 95% CI, 1.05-
2.10). The OR for PTB at< 37 weeks of gestation in studies that also matched for parity was 
similar and approached statistical significance at a 5% level of significance (OR, 1.47; 95% CI, 
1.01-2.44). The origin of the increase in PTB has yet to be determined (McDonald, Han et al., 
2010). Collectively these studies suggest that in comparison to spontaneously conceived 
twin gestations, twin pregnancies that result from ART are at increased for preterm birth 
especially between 32-36 weeks of gestation.  
5.2 Are singleton ART pregnancies at increased risk for preterm birth?  
One of the major questions regarding the association between ART and preterm birth was 
whether this effect is mainly due to the increase in the rate of multiple pregnancies or is it 
relevant also for singleton gestations (Jackson, Gibson et al., 2004; McGovern, Llorens et al., 
2004; Schieve, Meikle et al., 2002). Mounting evidence suggest that singleton pregnancies 
conceived following ART are at increased risk for preterm birth. Indeed: 1) In a Prospective 
follow-up study done in Denmark, including a total of 20,080 liveborn singletons, in 
comparison to fertile women, those who conceived following IVF/ICSI had a significant 
increase in the risk of preterm and very preterm delivery (Wisborg, Ingerslev et al., 2010b). 
2) Schieve et al compared the outcome of 62,551 infants born after ART treatments 
performed in 1996-2000. Secular trends in low birth weight (LBW), very low birth weight 
(VLBW), preterm delivery, preterm LBW, and term LBW were examined. Detailed analyses 
were performed for 6,377 infants conceived in 2000. Observed numbers were compared with 
expected using a reference population from the 2000 U.S. natality file. Singleton infants born 
after ART in 2000 had elevated risks for all outcomes in comparison with the general 
population of U.S. singletons: LBW standardized risk ratio 1.62 (95% CI 1.49, 1.75), VLBW 
1.79 (95% CI 1.45, 2.12), preterm delivery 1.41 (95% CI 1.32, 1.51), preterm LBW 1.74 (95% CI 
1.57, 1.90), and term LBW 1.39 (95% CI 1.19, 1.59) (Schieve, Meikle et al., 2002). 3) In a USA 
population based surveillance, singletons of mothers who received ART procedures were 
more likely to be born preterm, with low birthweight, and SGA than singleton infants 
conceived spontaneously. 4) A meta-analysis revealed that singletons born following IVF 
are twice as likely to be delivered preterm and die within 1 week of birth compared with the 
risk of those conceived spontaneously (McGovern et al., 2004). 5) Singletons conceived 
through the use of IVF are twice as likely to be born preterm and die within 1 week of birth 
as those not conceived through IVF and 2.7 times more likely to have a low birth weight 
(Hampton, 2004). 6) A meta-analysis that compiled information from 12,283 singleton births 
resulting from IVF pregnancies and 1.9 million spontaneously conceived singleton births 
noted a twofold increase in the risk of preterm delivery (Jackson et al., 2004). 7) According to 
the CDC report among the infants conceived through the use of ART, singletons that 
resulted from fetal reduction (either spontaneous or medically) had a higher rate of preterm 
birth (19%) than those who started as a singleton gestation (12%) (Figure 7). 
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Fig. 7. Proportion of preterm birth resulting from ART cycles using fresh non-donor eggs or 
embryos, by number of infants born-USA, CDC 2008. 
5.3 What are the possible mechanisms associated with the increased risk for preterm 
birth in ART pregnancies?  
The mechanisms in which assisted reproduction technologies increases the risk for preterm 
birth are still under investigation. Aside the contribution of ART to the increase number of 
multiple gestations (especially twins) that increases the risk for preterm delivery; the 
mechanisms leading to preterm delivery in singleton gestation conceived by ART have not 
been thoroughly investigated yet. Preliminary evidence suggests that underlying maternal 
conditions that may lead to infertility including insulin resistance and inflammation may 
contribute to this observation.  
5.3.1 Preterm parturition as a syndrome 
The implicit paradigm that has governed much of the study of preterm parturition is that 
term and preterm labor are fundamentally the same process except for the gestational age at 
which they occur (Romero, Espinoza et al., 2004a; Romero, Espinoza et al., 2006b) and share a 
‘common pathway’. The common pathway of human parturition is defined as the 
anatomical, physiological, biochemical, endocrinological, immunological, and clinical events 
that occur in the mother and/or fetus in both term and preterm labor. The fundamental 
difference between term and preterm parturition is that the former results from 
physiological activation of the common pathway, while preterm labor arises from 
pathological processes that extemporaneously activate one or more of the components of the 
common pathway of parturition.  
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Preterm labor (PTL) is the clinical presentation of different underlying mechanisms, 
(Romero, Espinoza et al., 2004c) including: intrauterine infection, (Romero, Sirtori et al., 1989; 
Romero, Mazor et al., 1988b; Minkoff, 1983; Goncalves, Chaiworapongsa et al., 2002) 
uteroplacental ischemia, (Romero, Sepulveda et al., 1993; Combs, Katz et al., 1993; Arias, 
1990; Arias, Rodriquez et al., 1993) uterine over-distention, (Hill, Breckle et al., 1987; Phelan, 
Park et al., 1990; Besinger and Carlson, 1995) cervical disease, (Romero, Mazor et al., 1993; 
Romero, Espinoza et al., 2006a; Romero, 1996; Heath, Southall et al., 1998; Hassan, Romero et 
al., 2000) abnormal allograft reaction, (Romero, Sepulveda et al., 1993) allergic phenomena, 
(Holloway, Warner et al., 2000; Jones, Miles et al., 1996; Rudolph, Reinicke et al., 1993) and 
endocrine disorders. (Belt, Baldassare et al., 1999; Allport, Pieber et al., 2001) The current 
taxonomy of disease in obstetrics is based on the clinical presentation of the mother and not 
on the mechanism of disease responsible for the clinical manifestations. The term ‘preterm 
labor’ does not indicate whether the condition is caused by infection, a vascular insult, 
uterine overdistension, an abnormal allogeneic recognition, stress, or some other 
pathological process. The same applies to pre-eclampsia, intrauterine growth restriction, 
fetal death, recurrent abortions, as well as, nausea and vomiting during pregnancy, and 
failure to progress in labor, in which the diagnoses simply describe the clinical 
manifestations without consideration of the specific etiology. The lack of recognition that 
these conditions simply represent a collection of signs and symptoms with little reference to 
the underlying mechanisms of disease may be responsible for the expectation that one 
diagnostic test and treatment will detect and cure each of these conditions. This has 
implications for the fundamental understanding of the biology of preterm parturition and 
the clinical strategies to diagnose, treat, and prevent spontaneous preterm labour (Romero, 
Espinoza et al., 2004a; Romero, Espinoza et al., 2006b). 
5.3.2 Intrauterine Infection and/or inflammation 
Systemic and subclinical infections are a leading cause of preterm birth. Indeed, 
pyelonephritis and pneumonia are frequently associated with the onset of premature labor 
and delivery. (Benedetti, Valle et al., 1982; Cunningham, Morris et al., 1973; Fan, Pastorek et 
al., 1987; Finland and Dublin T.D., 1939; Gilles, Lawson et al., 1969; Herd and Jordan, 1981; 
Hibbard, Thrupp et al., 1967; Kass, 1962; Madinger, Greenspoon et al., 1989; McLane, 1939; 
Oxhorn, 1955; Stevenson, Glasko A.J. et al., 1951; Wing and Troppoli D.V., 1930) Similarly, 
subclinical intrauterine infection is a frequent and important mechanism of disease leading 
to premature contraction, preterm labor and preterm birth. (Minkoff, 1983; Romero, Mazor 
et al., 1988a; Bang, 1987; Fidel, Jr., Romero et al., 1994; Kullander, 1977; McDuffie, Jr., 
Sherman et al., 1992; McKay and Wong, 1963; Rieder and Thomas, 1960; Romero, Munoz et 
al., 1994; Skarnes and Harper, 1972; Takeda and Tsuchiya I., 1953; Zahl and Bjerknes, 1943; 
Gomez, Ghezzi et al., 1995; Romero, Sirtori et al., 1989; Goncalves, Chaiworapongsa et al., 
2002) Microbiological and histo-pathological studies suggest that infection-related 
inflammation may account for 25 to 40% of cases of preterm deliveries.  
Goncalves et al (Goncalves, Chaiworapongsa et al., 2002) studied the rate of positive 
amniotic fluid cultures for microorganisms in women with preterm labor and intact 
membranes. The authors reviewed the results of amniotic fluid cultures from 33 studies and 
the prevalence of microbial invasion of amniotic fluid among patients with preterm labor 
was 12.8% (Goncalves, Chaiworapongsa et al., 2002; Romero, Espinoza et al., 2002), and 
about 50% of them were polymicrobial. The rate of microbial invasion of the amniotic cavity 
in patients with preterm labor and intact membrane is gestational age dependant. It is as 
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high as 45% at 23-26 weeks and decreases to 11.5% at 31-34 weeks of gestation (Watts, Krohn 
et al., 1992). Thus, the earlier the gestational age at preterm birth, the more likely that 
microbial invasion of the amniotic cavity is present (Watts, Krohn et al., 1992). In preterm 
PROM, the prevalence of a positive amniotic fluid culture for microorganisms is 
approximately 32.4%. (Goncalves, Chaiworapongsa et al., 2002; Romero, Espinoza et al., 
2002) However, when amniocenteses were performed at the time of the onset of labor, 75% 
of patients had microbial invasion of the amniotic cavity (Romero, Quintero et al., 1988), 
suggesting that some patients are already infected prior to the clinical rupture of 
membranes, while others are infected after the membrane have ruptured. The rate of 
microbial invasion of amniotic cavity among women presenting with a cervical insufficiency 
in the mid-trimester is around 33% (range 13%-52%) (Romero, Gonzalez et al., 1992; Bujold, 
Morency et al., 2008) and 45% to 51% in the early third trimester (Bujold, Morency et al., 
2008). In addition, a recent study has demonstrated that while only 8% of patients with 
cervical insufficiency had a positive amniotic fluid culture, 80% have intra-amniotic 
inflammation determined by a positive rapid MMP-8 kit (Lee, Romero et al., 2008). Patients 
with intra-amniotic inflammation and negative amniotic fluid culture had a shorter 
amniocentesis-to-delivery interval and a lower gestational age at delivery than patients 
without intra-amniotic infection/inflammation. In twin gestations, microbial invasion of the 
amniotic cavity occurs in 11.9% of patients presenting with preterm labor and deliver 
preterm (Romero, Manogue et al., 1989; Romero, Mazor et al., 1988b). The most common 
microbial organisms isolated from the amniotic fluid of patients with preterm parturition 
were genital mycoplasmas , Fusobacterium species Streptococcus agalactiae, Petostreptococcus 
spp., Fusobacterium spp., Staphylococcus aureus, Gardenerella vaginalis, Streptococcus viridans, 
and Bacterioides spp. (Alanen, 1998; Hitti, Riley et al., 1997; Averbuch, Mazor et al., 1995; 
Carroll, Papaioannou et al., 1996; Cotton, Hill et al., 1984; Coultrip and Grossman, 1992; 
Garite, Freeman et al., 1979; Zlatnik, Cruikshank et al., 1984; Romero, Quintero et al., 1988; 
Romero, Gonzalez et al., 1992) 
The association between infection and/or inflammation and preterm birth in ART 
pregnancies is implied from recently published data. A prospective cohort study that 
included 144,018 treatment cycles reported that tubal causes of infertility were associated 
with increased odds of preterm birth (Nelson and Lawlor, 2011). Kamiyama et al 
(Kamiyama, Teruya et al., 2004) reported that among women undergoing IVF-ET, those who 
had endotoxin concentrations > 200 pg/mL in menstrual effluent did not conceive, while 
30% of those with lower endotoxin concentrations got pregnant. Thus, preexisting 
endometrial microbial invasion with Gram negative bacteria is associated with failure of 
IVF-ET, either because of failure of implantation or the induction of sub clinical spontaneous 
abortion (Romero, Espinoza et al., 2004b). Endotoxin is a component of the cell wall of Gram 
negative bacteria and its detection in biological fluid is evidence of microbial invasion of a 
sterile compartment such as the amniotic cavity. An increased concentration in non-sterile 
body fluids such as cervical mucus or vaginal fluid is an indication of enlarged Gran-
negative microbial population and has been reported in women with bacterial vaginosis 
(Romero, Espinoza et al., 2004b). 
5.3.2.1 Bacterial vaginosis and preterm birth 
Bacterial vaginosis is a risk factor for spontaneous preterm birth with intact or ruptures 
membranes (Leitich, Bodner-Adler et al., 2003). The rate of bacterial vaginosis during 
pregnancy is 15-20%; however, 50% of these patients are asymptomatic. A meta-analysis 
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(Leitich, Bodner-Adler et al., 2003) of 18 studies (20,232 patients) concluded that bacterial 
vaginosis was associated with an increased risk for preterm delivery < 37 weeks of gestation 
(OR 2.19, 95%CI 1.54-3.12), and this effect was significant among singleton gestations, as 
well as among low and high risk pregnancies for preterm delivery. Detection of bacterial 
vaginosis <16 weeks of pregnancy was associated with an increased risk for preterm birth 
(OR 7.55, 95%CI 1.8-31.65) (Leitich, Bodner-Adler et al., 2003). Bacterial vaginosis was also 
found to be associated with intra-amniotic infection, histologic chorioamnionitis, preterm 
PROM, first trimester losses in women who conceived after in vitro fertilization, and second 
trimesters abortions, as well as post cesarean section endometritis and wound infection 
(Vidaeff and Ramin, 2006; Newton, Piper et al., 1997; Ralph, Rutherford et al., 1999; Llahi-
Camp, Rai et al., 1996; Watts, Krohn et al., 1990; Watts, Eschenbach et al., 1989; Chaim, Mazor 
et al., 1997).  
Patients who undergo IVF treatments have a rate of bacterial vaginosis of about 25% 
(Liversedge, Turner et al., 1999; Wilson, Ralph et al., 2002) which is higher than that observed 
in other groups of patients (11-15%) (Eschenbach, Gravett et al., 1984; Pavletic, Wolner-
Hanssen et al., 1999; Eschenbach, 1993; McGregor, Allen et al., 2001; McGregor and French, 
2000; Sobel, 2000; Ugwumadu, 2002). Moreover, bacterial vaginosis was more common 
among infertile patients with tubal occlusion (Wilson, Ralph et al., 2002), which is 
independently associated with an increased risk for preterm birth (Nelson and Lawlor, 
2011). Bacterial vaginosis was also more common in unovulatory women and those with 
unexplained infertility than in infertile couples due to male factor or endometriosis (Wilson, 
Ralph et al., 2002).  
Randomized clinical trials for the prevention of preterm birth by antibiotic treatment of 
patients with bacterial vaginosis have yielded contradictory results (McDonald, O'Loughlin 
et al., 1997; Kekki, Kurki et al., 2001; Ugwumadu, Manyonda et al., 2003; Guaschino, Ricci et 
al., 2003; Okun, Gronau et al., 2005; Shennan, Crawshaw et al., 2006; McDonald, Brocklehurst 
et al., 2005; Carey, Klebanoff et al., 2000). The randomized placebo control trial of the 
NICHD MFMU network included 1953 women with bacterial vaginosis who were assigned 
to treatment with oral metronidazol or placebo (Carey, Klebanoff et al., 2000). Treatment 
with metronidazol was not associated with a significant reduction in the rate of preterm 
birth. Moreover, a sub-analysis of high risk patients for preterm delivery demonstrated a 
higher rate of preterm delivery and preterm PROM in the treatment group (Carey, 
Klebanoff et al., 2000). A Cochrane review concluded that, overall, antibiotic treatment of 
bacterial vaginosis did not reduce the risk for preterm birth; however, treatment before 20 
weeks of gestation may reduce the risk for preterm delivery < 37 weeks (OR 0.72 95%CI 
0.55-0.95) (McDonald, Brocklehurst et al., 2007). In conclusion, treatment of bacterial 
vaginosis before 20 weeks of gestation in patients with a history of previous preterm birth, 
may reduce the risk for preterm PROM and low birthweight.  
5.3.3 Utero-placenta ischemia 
Abnormal placentation and vascular lesions in the fetal and maternal sides of the placenta 
are the second most prevalent lesions observed in patients who deliver preterm (Arias, 
Rodriquez et al., 1993). Several possible mechanisms can lead to such findings including 
vaginal and decidual bleeding, spontaneous or iatrogenic death of intrauterine sibling, 
and uterine vascular changes such as atherosclerosis that are more prevalent in older 
parturient. 
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First trimester bleeding among patients with singleton gestation who conceived by ART was 
associated with an increased risk for: 1) recurrent second-trimester (OR 4.56, 95% CI = 2.76–
7.56) and third-trimester bleeding (OR 2.85, 95% CI = 1.42– 5.73); 2) preterm PROM (OR 2.44, 
95% CI 1.38–4.31); 3) preterm contractions (OR 2.27, 95% CI 1.48–3.47) as well as increased 
the risk for preterm birth (OR 1.64, 95%CI = 1.05–2.55) and extreme preterm birth (OR 3.05, 
95%CI 1.12–8.31); and 4) NICU admissions (OR 1.75, 95% CI 1.21–2.54) (De Sutter, Bontinck 
et al., 2006). The origin of vaginal bleeding associated with preterm birth can be either 
decidual or placental.  
Vascular pathology is one of the mechanisms leading to decidual hemorrhage and 
subsequent preterm birth. Arias et al (Arias, Rodriquez et al., 1993) reported the rate of 
vascular lesions in placentae of patients with preterm labor was 34% and 35% of those with 
PROM, in comparison to only in 12% in those of women who delivered at term. The rate of 
failure of transformation of spiral arteries is higher among patients and preterm labor with 
intact membranes as well as those with preterm PROM than in patients who delivered at 
term (Kim, Bujold et al., 2003; Kim, Chaiworapongsa et al., 2002; Romero, Kusanovic et al., 
2011; Lockwood, Krikun et al., 2007). Moreover, the changes in the uterine vasculature 
associated with maternal age contribute as well for the vascular pathology. Indeed, 
Crawford et al (Crawford, Davis et al., 1997) studied whether uterine artery atherosclerosis 
is associated with known cardiovascular risk factors in women undergoing hysterectomy. 
Among the 59 premenopausal women, 55.9% had intimal thickening, 40.7% had simple 
plaques and 3.7% had complex lesions in the uterine artery samples. Among 
postmenopausal women, 40% had intimal fibrosis, 20% had simple plaques, and 40% had 
complex lesions. Postmenopausal status was correlated strongly with the presence of 
advanced atherosclerotic disease (P < 0.001). Postmenopausal women had significantly 
greater intimal area (P = 0.01), intimal area/medial area (P = 0.002), intimal area/vessel area 
(P =0.002), maximal intimal thickness/medial thickness (P = 0.01), and significantly less 
medial thickness (P <0.001). A significant linear correlation existed between age and the 
intimal/medial ratio among premenopausal women (P = 0.04) and postmenopausal women (P 
= 0.01). Patients with electrocardiogram (ECG) abnormalities had significantly greater 
intimal/medial area as well (P = 0.02). Hypertension was associated with complex lesions 
among the postmenopausal patients (P = 0.01). Preoperative cholesterol levels greater than 200 
mg/dL were associated with greater intimal thickness (P = 0.05) and intimal thickness/medial 
thickness (P = 0.03) (Crawford, Davis et al., 1997). Moreover, Naeye et al (Naeye, 1983) 
reported that sclerotic lesions in the myometrial arteries are a possible cause of underperfusion 
because the proportion of arteries with these lesions increased from 11% at age 17 to 19 years 
to 83% after the age of 36. This finding is in accord with the report that uterine artery PI during 
pregnancy increases with maternal age (Pirhonen, Bergersen et al., 2005). These observations 
are supported also by the clinical findings including an increased rate of SGA neonates among 
patients with preterm labor and intact membranes as well as those with preterm PROM, and 
the higher prevalence of low birthweight in ART pregnancies.  
Decidual bleeding is thought to play a role in the pathogenesis of preterm labor and preterm 
PROM leading to preterm birth. Indeed, hemosiderin deposition, that are regarded as a 
marker for bleeding are found in the decidua and retro-chorionic hematoma formation is 
present in 37.5% of patients who deliver preterm after PROM between 22 and 32 weeks of 
gestation, and 36% of patients with preterm delivery and intact membranes (Salafia, Lopez-
Zeno et al., 1995). In contrast these lesions are found only in 0.8% of placentas of those who 
deliver at term.  
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The effect of decidual bleeding on the activation of premature uterine contractions and/or 
rupture of membranes is thought to be mediated by thrombin (Lockwood, Krikun et al., 
2007; Lockwood, Paidas et al., 2009). The decidua is reach with tissue factor the most potent 
activator of the coagulation cascade. Thus, any minor decidual bleeding activates the 
coagulation cascade leading to the generation of thrombin thrombin (Stephenson, 
Lockwood et al.,2005; Lockwood, Toti et al., 2005; Sarno, Schatz et al., 2006; Lockwood, 
Krikun et al., 2007). Evidence in support of the increase activation of the coagulation cascade 
among patients with preterm labor and intact membranes as well as women with preterm 
PROM include: 1) women with spontaneous preterm labor without intra-amniotic infection 
or inflammation and women with vaginal bleeding who delivered preterm, have a lower 
median maternal plasma protein Z (a co factor of protein Z dependent protease inhibitor 
that inhibits the activity of factor X) than that of normal pregnant women (Kusanovic, 
Espinoza et al., 2007); 2) regardless to the presence of intra-amniotic infection/inflammation, 
women with preterm labor and intact membranes have a higher median tissue factor 
activity and a lower median tissue factor pathway inhibitor than those with a normal 
pregnancy 3) patients with preterm PROM have a higher median maternal plasma tissue 
factor concentration and a lower median TFPI concentrations than normal pregnant women 
(Erez, Espinoza et al., 2008); 4) patients with PTL as well as those with preterm PROM have a 
higher median maternal plasma thrombin-antithrombin III concentration than that of 
women with a normal pregnancy (Chaiworapongsa, Espinoza et al., 2002; Elovitz, Baron et 
al., 2001; Rosen, Kuczynski et al., 2001); and 5) maternal plasma thrombin-antithrombin III 
complex concentration in the mid trimester were lower in patients about to deliver preterm 
than in those who subsequently delivered at term (Hackney, Catov et al., 2010).  
Moreover, increased thrombin generation was detected not only in the maternal circulation 
but also in the amniotic fluid (Erez,Romero,et al.,2009). Women with preterm labor who 
delivered preterm had a higher median thrombin anti-thrombin III concentration than those 
who delivered at term (Erez, Romer et al., 2009). This was particularly evident among those 
without intra-amniotic infection/inflammation, in which elevated amniotic fluid of 
thrombin anti-thrombin complex concentrations were associated with a shorter 
amniocentesis to delivery interval and a lower gestational age at delivery than those with 
normal or low concentrations of this complex (Erez,Romero,et al.,2009). A vanishing twin 
can be an additional possible source for increase intrauterine thrombin generation that may 
lead to preterm birth. Indeed, vanishing twins among women who conceived by IVF/ICSI 
was associated with a higher rate of preterm birth <37 and <32 weeks of gestation, especially 
in the vanishing of the twin occur in later stages of gestation (Pinborg, Lidegaard et al., 
2005). A possible explanation for this observation is the report that intrauterine fetal demise 
is associated with an increased intra-amniotic thrombin generation (Erez, Gotsch et al., 2009). 
This may be the case also in patients with a vanishing twin, meaning, the increased 
thrombin generation associated with the dissolving of the dead twin increases the risk for 
preterm delivery of the surviving fetus. 
Thrombin can activate preterm parturition through several mechanisms: 1) it has a 
uterotonic activity, indeed, the administration of a whole blood into a non-pregnant uterus 
generated uterine contractions that were not evident when saline or heparinzed blood were 
introduced into the uterine cavity (Elovitz, Saunders et al., 2000; Elovitz, Baron et al., 2001); 
2) thrombin and activated coagulation factor X can induce pro inflammatory cytokines 
production (IL-6 and IL-1) that may leads to prostaglandins generation and premature 
myometrial activation and contractions (Lockwood, Toti et al., 2005); and 3) thrombin 
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activates matrix degrading enzymes such as matrix metalloproteneinases (MMPs) 1, 3 and 9 
that can degrade the chorioamniotic membranes leading to rupture of membranes (Rosen, 
Schatz et al., 2002; Stephenson, Lockwood et al., 2005). 
5.3.4 Uterine over-distention  
Women with a multiple pregnancy are at increased risk for spontaneous preterm labor and 
preterm birth. Intra-amniotic pressure remains relatively constant throughout gestation 
despite the growth of the fetus and placenta. This has been attributed to progressive 
myometrial relaxation due to the effects of progesterone and endogenous myometrial 
relaxants such as nitric oxide (Sladek, Westerhausen-Larson et al., 1999). Stretching can, 
however, induce increased myometrial contractility (Laudanski and Rocki, 1975), 
prostaglandin release (Kloeck and Jung, 1973), expression of gap junction protein or 
connexin-43 (Ou, Orsino et al., 1997), and increased oxytocin receptor in pregnant and non-
pregnant myometrium (Ou, Chen et al., 1998). The stretch-induced contraction- associated 
protein gene expression during pregnancy is inhibited by progesterone (Ou, Orsino et al., 
1997). The effect of stretch increases in late gestation and is maximal during labor as a 
consequence of the relative reduction in uterine growth compared with fetal growth and of 
the declining circulating and/or local concentrations of progesterone (Ticconi and Lye, 2002; 
Chow and Lye, 1994; Ou, Orsino et al., 1997).  
Mechanical stress induces activation of integrin receptors (Tzima, del Pozo et al., 2001), 
stretch-activated calcium channels (Holm, Rich et al., 2000; Farrugia, Holm et al., 1999), 
phosphorylation of platelet-derived growth factor receptor (Hu, Bock et al., 1998) and 
activation of G proteins (Li and Xu, 2000; Hu, Bock et al., 1998). Once mechanical force is 
sensed, it leads to activation of protein kinase C and mitogen- activated protein kinases, 
increased gene expression of c-fos and c-jun, and enhanced binding activity of transcription 
factor activator protein-1 (Shynlova, Oldenhof et al., 2002; Oldenhof, Shynlova et al., 2002; 
Mitchell and Lye, 2002; Mitchell and Lye, 2001; Piersanti and Lye, 1995; Lefebvre, Piersanti 
et al., 1995). Other effects of physical forces relevant to myometrium include increased 
expression of prostaglandin H synthase 2 (Wu, Ma et al., 1999), superoxide dismutase, and 
nitric oxide synthase. The nature of force/pressure-sensing mechanisms of the myometrium 
has yet to be determined. A role for integrins and their ligands has been proposed for other 
organs (Shyy and Chien, 2002; Lee, Millward-Sadler et al., 2002). Stretch may not only 
induce increased myometrial contractility but may also modify the contractile response 
through ‘mechanoelectrical feedback’ similar to the one reported in the heart. The 
chorioamniotic membranes are distended by 40% at 25–29 weeks of gestation, 60% at 30–34 
weeks of gestation, and 70% at term (Millar, Stollberg et al., 2000). Stretching of the 
membranes in vitro induces histological changes characterized by elongation of the amnion 
cells and increased production of collagenase activity and IL-8 (Maradny, Kanayama et al., 
1996; Maehara, Kanayama et al., 1996), while stretching of amnion cells in culture results in 
increased production of prostaglandin E2 (Kanayama and Fukamizu, 1989). Recent studies 
using an in vitro cell culture model for fetal membrane distension revealed upregulation of 
IL-8 and pre-B-cell colony-enhancing factor (Nemeth, Tashima et al., 2000). When fetal 
membrane explants were distended in an in vitro distension device to mimic the situation in 
vivo, and the gene expressions of distended explants were compared with that of 
nondistended explants, three genes, namely IL enhancer binding factor 2, huntingtin-
interacting protein 2, and interferon-stimulated gene encoding a 54 kDa protein, were found 
to be upregulated (Nemeth, Millar et al., 2000). Collectively, these observations suggest that 
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mechanical forces associated with uterine overdistension may result in activation of 
mechanisms leading to membrane rupture. 
5.3.5 Insulin resistance 
The association between infertility and maternal insulin resistance is well documented and 
polycystic ovary disease is its classical feature (Lobo, 1995; Barbieri, 1992; Ruutiainen and 
Seppala, 1991; Franks, Robinson et al., 1996; Davison, 1998; Taylor, 1998; Sills, Perloe et al., 
2000; Scarpitta and Sinagra, 2000; Gutmann and Corson, 2001; Nestler, Stovall et al., 2002; 
Moran and Norman, 2002; Ben-Shlomo, 2003). Indeed, these patients have a higher rate of 
infertility or sub fertility. The rate of pregnancy complications among patients with 
polycystic ovary disease is increased and women with PCOS demonstrated a significantly 
higher risk of developing gestational diabetes [odds ratio (OR) 2.94; 95% CI: 1.70–5.08], 
gestational hypertension (OR 3.67; 95% CI: 1.98–6.81), pre-eclampsia (OR 3.47; 95% CI: 1.95–
6.17) and preterm birth (OR 1.75; 95% CI: 1.16–2.62). Their babies had a significantly higher 
risk of admission to a neonatal intensive care unit (OR 2.31; 95% CI: 1.25–4.26) and a higher 
perinatal mortality (OR 3.07; 95% CI: 1.03–9.21), unrelated to multiple births (Boomsma, 
Eijkemans et al., 2006). Thus these findings suggest that insulin resistance may contribute to 
preterm birth in twin gestations especially among patients with PCOS. The exact 
mechanisms leading to preterm birth due to maternal insulin resistance are not clear, recent 
reports suggest that alteration in adipocytokines may be involved in this process (Mazaki-
Tovi, Romero et al., 2008; Mazaki-Tovi, Romero et al., 2009a; Mazaki-Tovi, Romero et al., 
2009b; Mazaki-Tovi, Romero et al., 2010; Mittal, Romero et al., 2009).  
5.3.6 Endocrine effect of ART 
The controlled ovarian hyperstimulation during ART cycles has endocrine implication that 
may contribute to the increasing rate of preterm birth in these patients. Human Chorionic 
Gonadotropin (hCG) induces the secretion of relaxin by the corpus luteum (Kristiansson, 
Svardsudd et al., 1996; Weiss, Goldsmith et al., 1993). Due to the ovarian hyperstimulation 
during ART cycle the maternal luteal mass is more prominent than that observed during 
spontaneously conceived pregnancies resulting in the significant increase in relaxin 
secretion in response to hCG, and indeed, pregnancies following ART were associated with 
hyper relaxinemia (Kristiansson, Svardsudd et al., 1996; Weiss, Goldsmith et al., 1993). 
Higher maternal relaxin concentrations were found to be significantly associated with 
preterm birth (Iams, Goldsmith et al., 2001; Vogel, Salvig et al., 2001; Vogel, Glavind-
Kristensen et al., 2002). Relaxin acts by promoting collagenolysis through inducing the 
activity of matrixmetaloproteinase (MMP) 1-3 and inhibiting tissue inhibitor of 
metalloprotease-1 (TIMP-1) (Palejwala, Stein et al., 2001); the net effect is remodeling and 
ripening of the uterine cervix and increased uterotonic activity. Progesterone can counter act 
relaxin activity by inducing an anti-inflammatory response and decrease the MMP 
concentrations and uterine contractility (Palejwala, Stein et al., 2001).  
6. Prevention of preterm birth 
The prevention of preterm birth is one of the major objectives of modern obstetrics. In the 
US there is an initiative to reduce the rate of preterm birth to 6.1% by 2010, and the March of 
Dimes has made this topic its main field of interest. In spite of all efforts, at present there is 
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no specific treatment for spontaneous preterm birth and this is attributed to the syndromic 
nature of preterm delivery that cannot be resolved by a single medication or intervention. 
Currently there is wide agreement regarding the beneficial effect of two treatments: (1) the 
administration of corticosteroids for patients at risk for preterm birth to reduced acute 
neonatal morbidity; and (2) prophylactic antibiotic treatment for patients with preterm 
PROM that has occurred from 24 to 32 weeks of gestation (Mercer, Miodovnik et al., 1997; 
Kenyon, Taylor et al., 2001) but not for preterm labor with intact membranes (Kenyon, 
Brocklehurst et al., 2008). This treatment has been proven to prolong pregnancy and reduce 
the rate of acute neonatal morbidity in patients with preterm PROM (Kenyon, Brocklehurst 
et al., 2008). However, the results of the follow up of children after 7 years were as follows: 
(1) In children who were born after preterm PROM, neither antibiotic regime was associated 
with a significant effect on the overall level of behavioral, medical status and academics 
achievements (Kenyon, Pike et al., 2008). (2) In contrast, prophylactic antibiotic treatment of 
patients with preterm labor had a negative effect on the children’s outcome at the age of 7. 
Treatment with erythromycin was associated with increased functional impairment of 
children of mother with preterm labor and intact membranes (Kenyon, Pike et al., 2008). The 
more worrisome outcome was the higher rate of cerebral palsy among children whose 
mothers were treated with erythromycin (OR 1.93, 95% CI 1.21–3.09) as well as in those 
treated with co-amoxicalve (OR 1.69, 95% CI 1.07–2.67) (Kenyon, Pike et al., 2008). Thus, 
prophylactic antibiotic treatment should not be administrated to patients and preterm labor 
with intact membranes. 
Yet, these treatments are targeted to reduce the rate of complications rather than to prevent 
the “disease”. In the recent years, attempts to prevent spontaneous preterm birth are mainly 
by two approaches: (1) the administration of progesterone to patients with a history of 
preterm birth or with a short sonographic cervix; and (2) placement of a cerclage for cervical 
os insufficiency. 
6.1 Progesterone for the prevention of preterm birth 
Progestogens administration for the prevention of recurrent abortion or preterm birth has 
been a subject of investigation (Papiernik-Berkhauer, 1970; LEVINE, 1964; BISHOP, 
RICHARDS et al., 1950; BISHOP and RICHARDS, 1952; Check, Chase et al., 1987; Tognoni, 
Ferrario et al., 1980; Gerhard, Gwinner et al., 1987; Johnson, Austin et al., 1975; Hauth, 
Gilstrap, III et al., 1983; Yemini, Borenstein et al., 1985; Hartikainen-Sorri, Kauppila et al., 
1980; Breart, Lanfranchi et al., 1979) and meta-analyses (Daya, 1989; Goldstein, Berrier et al., 
1989; Keirse, 1990) or several decades. However, progesterone gained a wide acceptance as a 
valid treatment for the prevention of preterm birth (2003) only after the publication of the 
studies by da Fonseca (da Fonseca, Bittar et al., 2003) and the NICHD MFMU (Meis, 
Klebanoff et al., 2003) who investigated its efficacy in the prevention of preterm birth in 
women with a history of preterm delivery.  
Da Fonseca et al. (da Fonseca, Bittar et al., 2003) reported the results of a randomized, 
double-blinded, placebo-controlled study including 142 high-risk singleton pregnancies 
including patients with: (1) at least one previous spontaneous preterm birth; (2) prophylactic 
cervical cerclage; or (3) a uterine malformation. The patients were randomized to receive 
either daily vaginal suppository of micronized progesterone (100 mg) or placebo, from 24 to 
34 weeks of gestation. The rate of preterm delivery <37 weeks and <34 weeks was lower in 
the progesterone group than in the placebo group (<37 weeks, progesterone: 13.8% vs. 
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placebo: 28.5%, p=0.03; and < 34 weeks, progesterone: 2.8% vs. 18.6%, p=0.002) (da Fonseca, 
Bittar et al., 2003). The authors concluded that prophylactic vaginal progesterone appeared 
to reduce the rate of preterm delivery in women at high risk for preterm birth (da Fonseca, 
Bittar et al., 2003). 
The NICHD-MFMU network (Meis, Klebanoff et al., 2003) reported the results of a 
multicenter double-blind, placebo-controlled clinical trial testing whether 17-hydroxy 
progesterone caproate (OHPC) administration can reduce the rate of preterm delivery in 
patients with a history of spontaneous preterm birth. The patients were enrolled at 16 to 20 
weeks of gestation and randomly assigned in a 2:1 ratio to receive either a weekly injection of 
250 mg of 17-OHPC or a weekly injection of placebo until delivery or 36 weeks of gestation. 
Treatment with 17-OHPC significantly reduced the rate of preterm delivery at less than 37 
weeks, less than 35 weeks, and less than 32 weeks of gestation (<37 weeks, RR 0.66; 95% CI 
0.54–0.81; <35 weeks, RR 0.67; 95% CI 0.48–0.93; and <32 weeks, RR 0.58; 95% CI 0.37–0.91]. 
Moreover, neonates born to women treated with 17-OHPC had significantly lower rates of 
NEC, IVH and need for supplemental oxygen (Meis, Klebanoff et al., 2003). Thus, among 
women at high risk for preterm delivery, a weekly injection of 17-OHPC resulted in a 
reduction in the rate of recurrent preterm birth and several neonatal complications (Meis, 
Klebanoff et al., 2003). The beneficial effect of 17-OHPC and vaginal progesterone in the 
reduction of preterm birth and of 17-OHPC in the reduction of the rate of neonates with low 
birth weight were further supported by systematic reviews meta-analyses and a Cochrane 
review (Sanchez-Ramos, Kaunitz et al., 2005; Dodd, Crowther et al., 2005; Coomarasamy, 
Thangaratinam et al., 2006; Mackenzie, Walker et al., 2006; Dodd, Flenady et al., 2006). 
In 2007, three new randomized clinical trials on the efficacy of progestogens in preventing 
preterm birth were reported (Rouse, Caritis et al., 2007; O'Brien, Adair et al., 2007; Fonseca, 
Celik et al., 2007). The recent randomized clinical trials yielded conflicting results. O’Brien et 
al (O'Brien, Adair et al., 2007) reported the results of a multinational, randomized, double-
blind, placebo-controlled trial of progesterone vaginal gel administration to patients with a 
history of spontaneous preterm birth between 20 to 35 weeks of gestation. Women were 
randomized, between 18 to 22 completed weeks of gestation, to receive daily treatment of 
progesterone vaginal polycarbophil-based gel (Crinone®, 8%, 90 mg) or placebo (Replens®) 
that were self-administered either until delivery, 37 weeks of gestation, or the occurrence of 
PROM. Vaginal progesterone did not reduce the rate of preterm birth at ≤32, ≤35, or ≤37 
weeks of gestation. Moreover, there were no differences in the neonatal and maternal 
outcomes (O'Brien, Adair et al., 2007). 
The beneficial effect of progesterone in patients with a sonographic short cervix has been 
recently reported (Facchinetti, Paganelli et al., 2007). A randomized prospective clinical trial 
(Facchinetti, Paganelli et al., 2007) in which women with preterm labor and intact 
membranes (25 to 33 6/7 weeks) were allocated to either observation or IM administration 
of 341 mg of 17-OHPC twice a week until 36 weeks of gestation or delivery was performed. 
Patients allocated to receive 17-OHPC had a longer sonographic cervical length than those 
in the observation group (Facchinetti, Paganelli et al., 2007); suggesting that progesterone 
may have major effects on the uterine cervix. 
Fonseca et al. (Fonseca, Celik et al., 2007) reported the results of a randomized clinical trial 
evaluating the efficacy of vaginal progesterone in reducing the rate of preterm birth in 
women with a sonographic short cervix (≤15 mm by transvaginal ultrasound between 20 to 
25 weeks of gestation). Women were allocated to daily vaginal administration of 200 mg of 
micronized progesterone or placebo (safflower oil) from 24 to 34 weeks. The frequency of 
www.intechopen.com
 
Assisted Reproduction and Preterm Birth 
 
25 
spontaneous preterm delivery <34 weeks was significantly lower in the progesterone group 
than that in patients allocated to placebo (19.2% vs. 34.4%; p=0.007) (Fonseca, Celik et al., 
2007). A secondary analysis of this trial indicated that among women without a history of 
delivery <34 weeks, the incidence of preterm birth was significantly lower in women 
receiving progesterone than in those allocated to placebo (RR 0.57, 95% CI 0.35–0.93) 
suggesting that progesterone may be beneficial to patients with a sonographic short cervix 
even without a history of preterm birth (Fonseca, Celik et al., 2007). 
The secondary retrospective analysis (Defranco, O'Brien et al., 2007) of the study by O’Brien 
et al (O'Brien, Adair et al., 2007). supports the findings of Fonseca et al (Fonseca, Celik et al., 
2007) that patients with a short cervix may benefit from vaginal progesterone 
administration. However, the authors (Defranco, O'Brien et al., 2007) reported that vaginal 
progesterone gel may have a beneficial effect in reducing preterm delivery <32 weeks of 
gestation at a sonographic cervical length of <28 mm (Defranco, O'Brien et al., 2007). These 
findings imply that the cutoff of 15 mm may be too stringent and progesterone may also 
work in women with a longer cervix. As the frequency of a cervix of ≤15 mm is 1.7% but that 
of <28 mm is about 10% (Iams, Goldenberg et al., 1996; Iams, Goldenberg et al., 2001; Iams, 
Johnson et al., 1995), this could expand the therapeutic range of progesterone.  
The study of De Franco et al (Defranco, O'Brien et al., 2007) provides the first hint that 
vaginal progesterone administration may improve infant outcome in properly selected 
patients. The frequency of NICU admission was lower in women with a cervical length of 
≤30 mm and <28 mm and who had received progesterone treatment than in those allocated 
to placebo. The same was the case for the duration of NICU length of stay (Defranco, 
O'Brien et al., 2007). However, these conclusions must be considered tentative because they 
derive from a secondary analysis which is intended to be hypothesis-generating.  
In contrast to the results in singleton gestations, the administration of progesterone for the 
prevention of preterm birth in twin gestation had no beneficial effect. Hartikainen-Sorri et al 
(Hartikainen-Sorri, Kauppila et al., 1980) more than twenty-five years ago, and recently 
Rouse et al (Rouse, Caritis et al., 2007) reported the results of a multicenter, placebo-
controlled, double-blind, randomized clinical trials of 17-OHPC for prevention of preterm 
birth in twin pregnancies. Both studies concluded that there was no beneficial effect of 17-
OHPC administration for the prevention of preterm birth in twin gestation. 
6.2 The role of cervical cerclage in the prevention of preterm birth 
Keeping with the view that cervical insufficiency is a mechanical disorder of the cervix, 
placement of a cervical stitch (cerclage) has been proposed as a treatment for this disorder. 
The clinical value of cervical cerclage has been subject of many observational and 
randomized clinical trials (To, Palaniappan et al., 2002; 1993; Althuisius, Dekker et al., 2002; 
Althuisius, Dekker et al., 2000; Althuisius, Dekker et al., 2001; Althuisius, Dekker et al., 2003; 
Lazar, Gueguen et al., 1984; To, Alfirevic et al., 2004) and systematic reviews (Belej-Rak, 
Okun et al., 2003; Drakeley, Roberts et al., 2003a; Drakeley, Roberts et al., 2003b). Yet 
controversies still exist regarding the subset of patients who will benefit from cerclage. 
The current evidence suggests the following: (1) Women who are at low risk for preterm 
delivery (by history) and have a sonographic short cervix (≤15 mm) will not benefit from 
cerclage (To, Alfirevic et al., 2004). (2) The benefit of cerclage in women who have a high risk 
for preterm birth, both by history and a sonographic short cervix observed during the 
current pregnancy, is controversial (Berghella, Odibo et al., 2004; Rust, Atlas et al., 2000; 
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Rust, Atlas et al., 2001; Althuisius, Dekker et al., 2000; Althuisius, Dekker et al., 2001). 
However, a recent randomize clinical trial conducted by the NICHD MFM network among 
patients with a prior preterm birth <34 weeks of gestation. Patients with a cervical length 
<25 mm randomly assigned to cerclage reported a beneficial effect of cerclage (Owen, 
Hankins et al., 2009). This benefit was highly concentrated in women with very short 
cervical length (<15 mm) (Owen, Hankins et al., 2009). (3) Among patients at risk for preterm 
delivery, serial sonographic examinations of the cervix followed by cerclage in those who 
shortened the cervix is a reasonable alternative to prophylactic placement of cerclage based 
upon uncontrolled studies (Guzman, Forster et al., 1998; To, Alfirevic et al., 2004; Higgins, 
Kornman et al., 2004). (4) The role of prophylactic cerclage in high-risk patients without a 
sonographic short cervix for the prevention of preterm delivery/midtrimester abortion (by 
history) is unclear (1993; Althuisius, Dekker et al., 2001; Lazar, Gueguen et al., 1984; Odibo, 
Elkousy et al., 2003; Rush, Isaacs et al., 1984). (5) In one trial, emergency cerclage combined 
with indomethacin administration appeared to reduce the rate of preterm delivery in 
patients with the clinical presentation of “cervical insufficiency” (Althuisius, Dekker et al., 
2003). This evidence indicates that only patients with the clinical presentation of “acute 
cervical insufficiency” and those with a previous history consistent with “cervical 
insufficiency” or spontaneous preterm birth and a progressive shortening of the cervix 
demonstrated by ultrasound may benefit from cerclage placement (Althuisius, Dekker et al., 
2001; Althuisius, Dekker et al., 2003; Berghella, Rafael et al., 2011; Berghella, Keeler et al., 
2010; Owen, Hankins et al., 2009). The inflammatory status of the endocervix may be an 
additional criterion to identify those patients that could benefit from cerclage placement and 
those for whom this intervention may be harmful. (Sakai, Shiozaki et al., 2006) 
6.3 The role of progesterone in primary prevention of preterm birth 
A recent study by Hassan et al (Hassan, Romero et al., 2011)raised for the first time the 
possibility of primary prevention of preterm delivery. The study included patients with a 
short cervix (cervical length between 10-20 mm) who were randomized at 19-24 weeks to the 
administration of daily vaginal progesterone gel vs. placebo, regardless to their obstetrical 
history. 32,091 were screened, of them 733 had a short cervix, and 465 were randomized. 
Women at the progesterone group had a significant reduction in the rate of preterm birth 
before 33 weeks of gestation and a significant lower rate of neonatal complications in 
comparison to those in the placebo group (Hassan, Romero et al., 2011). Thus, cervical length 
is an effective risk assessment tool for the identification of patients at risk for preterm birth 
and vaginal progesterone gel can prevent preterm delivery in a significant portion of 
patients with a short cervix.  
7. Summary 
Assisted reproduction aids a substantial proportion of women to conceive and deliver, 
however, these pregnancies are at increased risk for preterm birth. Some of the mechanisms 
leading to preterm parturition in these patients are inherited from the nature of conception like 
multiple gestations along with their complications. In addition, especially among singleton 
gestations, ART are an independent risk factor for preterm delivery and this may result from 
the underlying mechanisms leading to maternal infertility like infection/inflammation of the 
genital tract as well as other mechanisms. Thus, women who conceived following ART cycles 
should be followed and treated as a patient at risk for preterm birth.  
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